Abstract
The principal function of the parathyroid hormone (PTH) is maintenance of calcium plasmatic levels, withdrawing the calcium from bone tissue, reabsorbing it from the glomerular filtrate, and indirectly increasing its intestinal absorption by stimulating active vitamin D (calcitriol) production. Additionally, the PTH prompts an increase in urinary excretion of phosphorus and bicarbonate, seeking a larger quantity of free calcium available in circulation. Two mechanisms may alter its function, limiting its control on calcium: insufficient PTH production by the parathyroids (hypoparathyroidism), or a resistance against its action in target tissues (pseudohypoparathyroidism). In both cases, there are significantly reduced levels of plasmatic calcium associated with hyperphosphatemia. Clinical cases are characterized by nervous hyperexcitability, with paresthesia, cramps, tetany, hyperreflexia, convulsions, and tetanic crisis. Abnormalities such as cataracts and basal ganglia calcification are also typical of these diseases. Treatment consists of oral calcium supplementation associated with increased doses of vitamin D derivatives.
Subject
General Medicine,Endocrinology, Diabetes and Metabolism
Reference41 articles.
1. Primer on the metabolic bone diseases and disorders of mineral metabolism;Broadus AE,2003
2. Electrolyte quintet: calcium;Bushinsky DA;Lancet,1998
3. Hypocalcemic emergencies;Tohme JF;Endocrinol Metab Clin North Am,1993
4. Endocrinology;Levine M,2001
5. Diagnosis and management of electrolyte emergencies;Weiss-Guillet EM;Best Pract Res Clin Endocrinol Metab,2001
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献